Page last updated: 2024-11-02

oxyphenbutazone and Giant Cell Arteritis

oxyphenbutazone has been researched along with Giant Cell Arteritis in 2 studies

Oxyphenbutazone: A non-steroidal anti-inflammatory drug. Oxyphenbutazone eyedrops have been used abroad in the management of postoperative ocular inflammation, superficial eye injuries, and episcleritis. (From AMA, Drug Evaluations Annual, 1994, p2000) It had been used by mouth in rheumatic disorders such as ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis but such use is no longer considered justified owing to the risk of severe hematological adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p27)
oxyphenbutazone : A metabolite of phenylbutazone obtained by hydroxylation at position 4 of one of the phenyl rings. Commonly used (as its hydrate) to treat pain, swelling and stiffness associated with arthritis and gout, it was withdrawn from the market 1984 following association with blood dyscrasis and Stevens-Johnson syndrome.

Giant Cell Arteritis: A systemic autoimmune disorder that typically affects medium and large ARTERIES, usually leading to occlusive granulomatous vasculitis with transmural infiltrate containing multinucleated GIANT CELLS. The TEMPORAL ARTERY is commonly involved. This disorder appears primarily in people over the age of 50. Symptoms include FEVER; FATIGUE; HEADACHE; visual impairment; pain in the jaw and tongue; and aggravation of pain by cold temperatures. (From Adams et al., Principles of Neurology, 6th ed)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wadman, B1
Werner, I1
Watson, PG1
Lobascher, D1

Trials

1 trial available for oxyphenbutazone and Giant Cell Arteritis

ArticleYear
The diagnosis and management of episcleritis and scleritis.
    Transactions of the ophthalmological societies of the United Kingdom, 1965, Volume: 85

    Topics: Arteritis; Arthritis, Rheumatoid; Behcet Syndrome; Clinical Trials as Topic; Deafness; Eczema; Epine

1965

Other Studies

1 other study available for oxyphenbutazone and Giant Cell Arteritis

ArticleYear
Therapeutic hazards of phenylbutazone and oxyphenbutazone in polymyalgia rheumatica.
    Lancet (London, England), 1967, Mar-18, Volume: 1, Issue:7490

    Topics: Aged; Female; Giant Cell Arteritis; Humans; Male; Middle Aged; Oxyphenbutazone; Phenylbutazone; Poly

1967